ALPS Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-799
| Closed | -$275K | – | 868 |
|
|
2019
Q3 | $275K | Sell |
799
-41
| -5% | -$14.1K | ﹤0.01% | 817 |
|
|
2019
Q2 | $773K | Sell |
840
-119
| -12% | -$110K | 0.01% | 391 |
|
|
2019
Q1 | $1.53M | Buy |
959
+43
| +5% | +$68.6K | 0.01% | 257 |
|
|
2018
Q4 | $1.71M | Buy |
916
+216
| +31% | +$404K | 0.01% | 234 |
|
|
2018
Q3 | $1.65M | Buy |
700
+131
| +23% | +$309K | 0.01% | 275 |
|
|
2018
Q2 | $1.96M | Buy |
569
+44
| +8% | +$152K | 0.01% | 230 |
|
|
2018
Q1 | $1.49M | Buy |
525
+93
| +22% | +$264K | 0.01% | 243 |
|
|
2017
Q4 | $1.11M | Buy |
432
+49
| +13% | +$126K | 0.01% | 243 |
|
|
2017
Q3 | $1.09M | Buy |
383
+32
| +9% | +$90.8K | 0.01% | 235 |
|
|
2017
Q2 | $830K | Buy |
351
+18
| +5% | +$42.6K | 0.01% | 257 |
|
|
2017
Q1 | $838K | Sell |
333
-36
| -10% | -$90.6K | 0.01% | 233 |
|
|
2016
Q4 | $833K | Sell |
369
-121
| -25% | -$273K | 0.01% | 231 |
|
|
2016
Q3 | $1.23M | Sell |
490
-49
| -9% | -$123K | 0.01% | 212 |
|
|
2016
Q2 | $1.65M | Buy |
539
+110
| +26% | +$337K | 0.01% | 184 |
|
|
2016
Q1 | $1.36M | Sell |
429
-45
| -9% | -$143K | 0.01% | 171 |
|
|
2015
Q4 | $2.43M | Sell |
474
-85
| -15% | -$436K | 0.02% | 162 |
|
|
2015
Q3 | $17.8K | Buy |
559
+205
| +58% | +$6.52K | 0.02% | 178 |
|
|
2015
Q2 | $1.42M | Buy |
354
+178
| +101% | +$712K | 0.01% | 188 |
|
|
2015
Q1 | $702K | Buy |
+176
| New | +$702K | 0.01% | 202 |
|